Henric Bjorn Bjarke's Insider Trades & SAST Disclosures
Henric Bjorn Bjarke's most recent trade in Inozyme Pharma Inc was a trade of 21,500 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on Dec. 15, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Henric Bjorn Bjarke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 15 Dec 2022 | 21,500 | 105,441 | - | 1.4 | 29,885 | Common Stock |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Grant, award, or other acquisition of securities at price $ 2.28 per share. | 30 Sep 2022 | 3,315 | 83,941 | - | 2.3 | 7,558 | Common Stock |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 19 Apr 2022 | 27,100 | 80,626 | - | 3.7 | 99,999 | Common Stock |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 115,000 | 115,000 | - | - | Stock option (right to buy) | |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 51,000 | 51,000 | - | - | Stock option (right to buy) | |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | SVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 51,105 | 51,105 | - | - | Stock Option (right to buy) | |
| Inozyme Pharma Inc | Henric Bjorn Bjarke | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 32,905 | 32,905 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges